XenoPort, located Santa Clara, Calif., is a publicly held biopharmaceutical company, which develops products that harness the body's intrinsic transport systems to improve the oral absorption, distribution and pharmacokinetics of drugs. The company applies an integrated technology platform, consisting of transporter genomics, assay technology and proprietary chemistries to engineer drug...